The Greenrose Holding Company Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Nicole Conboy
- Full Time Employees
- 91
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 111 Broadway Amityville NY United States of America 11701
- IPO Date
- May 21, 2020
- CIK
- 0001790665
- Website
- greenroseholdings.com
- Similar Companies
- Business
- The Greenrose Holding Company Inc. engages primarily in the cultivation, processing, and production of cannabis and cannabinoid-based products primarily for the medical and recreational cannabis markets. Its core offerings include cannabis flower, concentrates, oils, edibles, and other derivative products manufactured under several cannabis brand portfolios. The company operates vertically across cultivation facilities, production processing sites, and retail dispensaries with a multi-state operational footprint notably in Connecticut and Arizona. Founded in 2014 and headquartered in Amityville, New York, Greenrose manages a vertically integrated platform combining award-winning cultivation genetics and scalable growing methods. Recent major company changes include the completion of a business combination with Theraplant, LLC in late 2021, which marked its transition to a publicly traded entity under the name The Greenrose Holding Company Inc. The firm has strategically expanded through acquisitions, notably including the purchase of True Harvest, LLC’s assets in Arizona, thereby establishing a strong cultivation presence in the southwestern U.S. This expansion supports Greenrose’s objective to capture growth in emerging recreational cannabis markets. The company has also pursued further acquisitions such as Shango Holdings, Inc. and Futureworks LLC (d/b/a The Health Center) to consolidate its position as a leading multi-state cannabis operator. In 2022, Greenrose revised its business outlook to reflect regulatory delays in recreational cannabis sales start dates but maintained focus on operational efficiency and organic growth across its cultivation and production assets. Greenrose is positioned within the specialty and generic drug manufacturing segment of the healthcare industry, targeting medical and adult-use cannabis consumers across the U.S. Its strategic initiatives leverage capital raised through senior secured credit facilities and equity offerings to fuel expansion and product development. Despite recent operational challenges and a bankruptcy filing in mid-2024 that initiated liquidation proceedings, Greenrose’s foundational business activities have centered on providing high-quality cannabis products across multiple states with an emphasis on scalable cultivation technology and vertical integration to drive revenue growth and market presence. This comprehensive operational portfolio and acquisition-driven expansion define Greenrose Holding Company's role as a vertically integrated cannabis cultivator and producer with ongoing strategic attempts at market consolidation and portfolio diversification within the U.S. cannabis industry.
Where Is The Value In Cannabis Stocks?
The Greenrose Holding Company Inc.'s (GNRS) CEO Mickey Harley on Q2 2022 Results - Earnings Call Transcript
The Greenrose Holding Company sees its 2Q revenue surge, driven by expanding cultivation capacity in two US states
The Greenrose Holding Company to Hold Rescheduled Second Quarter 2022 Conference Call on August 22, 2022 at 5:00 p.m. ET
The Greenrose Holding Company appoints new chief financial officer, as well as a new director to its board
The Greenrose Holding Company sees 1Q revenue bump thanks to acquisition of cannabis operator True Harvest
The Greenrose Holding Company Inc. CEO Mickey Harley on Q1 2022 Results - Earnings Call Transcript
The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET
Key Trends Coming Out Of Q1 2022
Greenrose Holding: A Next Big MSO
Greenrose Holding's Stock Jumps On Closing $57.6M Acquisition Of Arizona Craft Cannabis Producer
The Greenrose Holding Company closes asset purchase of True Harvest
The Greenrose Holding Company closes asset purchase of True Harvest LLC
Greenrose Acquisition says shareholders approve business combination
3 Cannabis SPACs Hoping to Get High
OTC Markets Group Welcomes Greenrose Acquisition Corp. to OTCQX
This Hot New Cannabis SPAC Gives Investors Exposure to Some of the Hottest Markets